Advertisement

Spinal Tech

At the 12th Annual Spine, Orthopedic and Pain Management Driven ASC Conference in Chicago on June 12, Hallett Mathews, MD, executive vice president and CMO for Paradigm Spine, discussed motion preserving MIS stabilization for stenosis surgery in ambulatory surgery centers.

Spine device company K2M closed on their initial public offering earlier this year and the IPO's underwriters exercised their over-allotment option, according to a company news release.

Advertisement

Two recently-published clinical journal articles examine the cost-effectiveness and safety of performing lumbar spine surgery with fusion as well as Paradigm Spine's coflex Interlaminar Stabilization device on an outpatient basis for spinal stenosis patients.

Orthocell, a biotherapeutic technology company, has launched an initial public offering, according to a Health Point Capital report.

Advertisement